Improving the biopharmaceutical performance of azole antifungals: a comparative study of solid dispersion and co-crystallization of ketoconazole and itraconazole

Payal Dasgupta; Bipul Nath; Apurba  Talukdar; Atanu  Sarma; Sidhartha Jyoti  Bora

doi:10.69857/joapr.v14i4.2144

Authors

Payal Dasgupta Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India
Bipul Nath Department of Pharmacy, Royal School of Pharmacy, The Assam Royal Global University, Betkuchi, Guwahati-781035, Kamrup, Assam, India
Apurba Talukdar NETES Institute of Pharmaceutical Science (NIPS), NEMCARE Group of Institutions, Santipur, Mirza-781125, Kamrup, Assam, India.
Atanu Sarma NEPEDS College of Pharmaceutical Sciences, Gandhi Nagar, Tetelia, Khetri-782403, Assam, India
Sidhartha Jyoti Bora NEPEDS College of Pharmaceutical Sciences, Gandhi Nagar, Tetelia, Khetri-782403, Assam, India

DOI:

https://doi.org/10.69857/joapr.v14i4.2144

Keywords:

Ketoconazole, Pharmaceutical co-crystals, Solubility enhancement, Dissolution kinetics, Itraconazole, Solid dispersion\

Abstract

Background: Oral bioavailability of BCS class II azole antifungals, ketoconazole and itraconazole, is hampered by low aqueous solubility. Improving solubility and dissolution is necessary for greater therapeutic efficacy. This research compared two approaches: solid dispersion and pharmaceutical co-crystallization to improve their biopharmaceutical properties. Methodology: Solid dispersions were prepared using the organic solvent evaporation technique with PEG-10000 for ketoconazole and HPMCE50 for itraconazole. Co-crystals with benzoic and tartaric acids were studied by FT-IR, DSC, and PXRD. Optimized formulations were compressed into tablets and analyzed for pharmacopoeial parameters, dissolution, release kinetics, and ICH stability. Results and Discussion: Saturation solubility investigations revealed that, compared to amorphization, solid dispersions exhibited more efficient enhancement due to the combined effect of amorphous enrichment and polymer solubilization. Tartaric acid co-crystals could increase solubility by crystal lattice modification. cc-Tabs showed burst release profiles, while SDs gave controlled drug release. The release of drug was in accordance with the first-order and Korsmeyer–Peppas models with anomalous transport, and was sustained for six months. The low aqueous solubility of azole antifungals restricts their oral bioavailability. The solubility and dissolution of ketoconazole and itraconazole were enhanced by solid dispersion and co-crystallization. Solid dispersions provided superior amorphous stability and extended-release, while co-crystals led to faster initial dissolution and better early drug availability. Conclusion: Both approaches were successful in improving solubility, dissolution, and stability. Both SDs modulated drug release kinetics; sustained-release profiles were obtained from the solid dispersions, and fast dissolution was favored by co-crystallization, thus providing both as viable approaches for oral delivery of poorly soluble azole antifungals.

Downloads

Download data is not yet available.

References

Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines, 10(9), 2055 (2022) https://doi.org/10.3390/biomedicines10092055

Quodbach J, Preis E, Karkossa F, Winck J, Finke JH, Steiner D. Novel strategies for the formulation of poorly water-soluble drug substances by different physical modification strategies with a focus on peroral applications. Pharmaceuticals, 18(8), 1089 (2025) https://doi.org/10.3390/ph18081089

Kshirsagar MM, Chatale BC, Dyawanapelly S, Vora LK, Amin PD. Continuous processing strategies for amorphous solid dispersions of itraconazole: impact of polymer selection and manufacturing techniques. Pharmaceutics, 17(9), 1090 (2025) https://doi.org/10.3390/pharmaceutics17091090

Baldea I, Moldovan R, Nagy AL, Bolfa P, Decea R, Miclaus MO, et al. Ketoconazole-fumaric acid pharmaceutical cocrystal: from formulation design for bioavailability improvement to biocompatibility testing and antifungal efficacy evaluation. Int J Mol Sci, 25(24), 13346 (2024) https://doi.org/10.3390/ijms252413346

Fitriani L, Syafitri NA, Siregar MN, Jessica A, Zaini E. Co-amorphous of etoricoxib and citric acid with enhancement in solubility and dissolution. Res J Pharm Technol, 18(11), 5358–5364 (2025) https://doi.org/10.52711/0974-360X.2024.00772

Ohashi R, Otake S, Murata T, Watari R, Yoshida S, Kitade M, et al. Selection of solubility enhancement technologies for S-892216, a novel COVID-19 drug candidate. Pharmaceutics, 17(12), 1627 (2025) https://doi.org/10.3390/pharmaceutics17121627

Vasilev NA, Surov AO, Voronin AP, Drozd KV, Perlovich GL. Novel cocrystals of itraconazole: insights from phase diagrams, formation thermodynamics and solubility. Int J Pharm, 599, 120441 (2021) https://doi.org/10.1016/j.ijpharm.2021.120441

Yu H, Zhang L, Liu M, Yang D, He G, Zhang B, et al. Enhancing solubility and dissolution rate of antifungal drug ketoconazole through crystal engineering. Pharmaceuticals, 16(10), 1349 (2023) https://doi.org/10.3390/ph16101349

Sharma D, Kumar D, Sehrawat S, Kumar D, Kumar S. Various aspects of solid dispersion technology: a review. J Drug Deliv Ther, 18(4), 267–277 (2025) https://doi.org/10.52711/0974-360X.2025.00267

Mhaske GS, Deshmukh AS, Awate SS, Satkar SS, Gurav MV, Ghatpande KS, et al. Surface solid dispersion technique for solubility enhancement of nifedipine. Curr Indian Sci, 3, e2210299X338910 (2025) https://doi.org/10.2174/012210299X338910241218114154

Nyamba I, Sombié CB, Yabré M, Zimé-Diawara H, Yaméogo J, Ouédraogo S, et al. Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs. Eur J Pharm Biopharm, 204, 114513 (2024) https://doi.org/10.1016/j.ejpb.2024.114513

Umekar M, Raut N, Mahore J, Malode D, Koche S, Manghani M, et al. Comparative insights into polymers for solid dispersions: mechanisms, sustainability, regulatory and clinical perspectives. Polym Plast Technol Mater, 64(16), 2429–2451 (2025) https://doi.org/10.1080/25740881.2025.2546457

Mannala T. Hot melt extrusion: a viable option for implementing continuous manufacturing in the pharmaceutical industry. J Drug Deliv Ther, 15(10), 87–89 (2025) https://doi.org/10.22270/jddt.v15i10.7381

Bhatta HP, Han HK, Maharjan R, Jeong SH. Recent techniques to improve amorphous dispersion performance with quality design, physicochemical monitoring, molecular simulation, and machine learning. Pharmaceutics, 17(10), 1249 (2025) https://doi.org/10.3390/pharmaceutics17101249

Kumar C, Nanda A. Novel microwave-assisted solid dispersion technology enhances piroxicam dissolution and therapeutic efficacy: an in vitro and in vivo study. J Appl Pharm Res, 13(1), 49–61 (2025) https://doi.org/10.69857/joapr.v13i1.921

Khazir S, Shah A, Parambil J, Dar A. Crystal engineering considerations for pharmaceutical co-crystals. CrystEngComm, 27 (2025) https://doi.org/10.1039/D5CE00820D

Anand R, Kumar A, Nanda A. Pharmaceutical co-crystals: design, development and applications. Drug Deliv Lett, 10(3), 169–184 (2020) https://doi.org/10.2174/2210303109666191211145144

Raheem Thayyil A, Juturu T, Nayak S, Kamath S. Pharmaceutical co-crystallization: regulatory aspects, design, characterization, and applications. Adv Pharm Bull, 10(2), 203–212 (2020) https://doi.org/10.34172/apb.2020.024

O'Sullivan A, Long B, Verma V, Ryan KM, Padrela L. Solid-state and particle size control of pharmaceutical cocrystals using atomization-based techniques. Int J Pharm, 621, 121798 (2022) https://doi.org/10.1016/j.ijpharm.2022.121798

Pawar N, Saha A, Nandan N, Parambil JV. Solution cocrystallization: a scalable approach for cocrystal production. Crystals, 11(3), 303 (2021) https://doi.org/10.3390/cryst11030303

Li J, Wang X, Yu D, Zhoujin Y, Wang K. Molecular complexes of drug combinations: a review of cocrystals, salts, coamorphous systems and amorphous solid dispersions. Int J Pharm, 648, 123555 (2023) https://doi.org/10.1016/j.ijpharm.2023.123555

Budiman A, Puluhulawa LE, Mo'o FRC, Thomas N, Biu MTS, Saputri FA, et al. Comparative evaluation of ternary amorphous solid dispersions: identifying optimal excipient systems for enhancing drug solubility. Int J Pharm X, 10, 100461 (2025) https://doi.org/10.1016/j.ijpx.2025.100461

Vullendula SKA, Nair AR, Yarlagadda DL, Sree KN, Bhat K, Dengale SJ. Polymeric solid dispersion vs co amorphous technology: a critical comparison. J Drug Deliv Sci Technol, 78, 103980 (2022) https://doi.org/10.1016/j.jddst.2022.103980

S'ari M, Blade H, Cosgrove S, Drummond-Brydson R, Hondow N, Hughes LP, et al. Characterization of amorphous solid dispersions and identification of low levels of crystallinity by transmission electron microscopy. Mol Pharm, 18(5), 1905–1919 (2021) https://doi.org/10.1021/acs.molpharmaceut.0c00918

Zuccari G, Russo E, Villa C, Zorzoli A, Marimpietri D, Marchitto L, et al. Preparation and characterization of amorphous solid dispersions for the solubilization of fenretinide. Pharmaceuticals, 16(3), 388 (2023) https://doi.org/10.3390/ph16030388